Sentences with phrase «of therapeutic cancer vaccines»

Through the CIC program, the Cancer Research Institute conducts a number of important initiatives that seek among other things to build consensus across the field on key issues, to develop and implement new standards for carrying out and reporting immunological monitoring assays of therapeutic cancer vaccines, and to establish and promote the adoption of new criteria for evaluating the clinical impact of cancer immunotherapies.

Celis» lab has shown how poly - IC, which behaves like the genetic material of viruses to also get the attention of the immune system, can improve the effectiveness of therapeutic cancer vaccines.

Not exact matches

On the morning of Monday, October 3, the Nobel Committee announced that immunologist Ralph Steinman had won the Nobel Prize in Medicine for his work on immune cells and a discovery that led to the first therapeutic cancer vaccine.

One of the most contentious and closely scrutinized decisions before the FDA concerns Provenge, a proposed therapeutic vaccine made by Dendreon for use against prostate cancer.

Unlike preventive vaccinations, therapeutic cancer vaccines of this type are meant to kill established cancer cells.

Currently there are only a few approved therapeutic cancer vaccines, none of which are approved for the treatment of GBM.

A new therapeutic vaccine, GTL001, developed by Genticel to clear HPV strains 16 and 18 — the types most likely to cause cancer — is being evaluated for safety in a Phase I clinical trial at the University of Louisville.

The second focus on my research is the development of novel therapeutic vaccine approaches for cancer.

Drew Pardoll, Glenn Dranoff, Elizabeth Jaffee, Hyam Levitsky, and colleagues conduct preclinical studies showing that a vaccine composed of tumor cells irradiated and genetically modified to produce immune system growth factor GM - CSF (granulocyte - macrophage colony - stimulating factor)-- which would become known as the therapeutic cancer vaccine GVAX — could induce potent, specific, and long - lasting anti-tumor immunity in multiple mouse tumor models.

The trial was part of the Cancer Vaccine Collaborative, a joint program between the Cancer Research Institute and the Ludwig Institute for Cancer Research to develop therapeutic cancer vacCancer Vaccine Collaborative, a joint program between the Cancer Research Institute and the Ludwig Institute for Cancer Research to develop therapeutic cancer vacCancer Research Institute and the Ludwig Institute for Cancer Research to develop therapeutic cancer vacCancer Research to develop therapeutic cancer vaccancer vaccines.

Lizée and colleagues are developing a different type of vaccine called a therapeutic vaccine, which triggers an attack against established cancer.

This includes utilizing a modified chimpanzee virus as a vaccine carrier to induce an immune response against HIV, and a new therapeutic vaccine against human papillomavirus (HPV), a leading cause of cervical cancer.

A fact sheet that provides an overview of how the immune system functions and describes the actions of biological therapies, such as monoclonal antibodies, cytokines, therapeutic vaccines, the bacterium bacillus Calmet - Guérin, cancer - killing viruses, gene therapy, and adoptive T - cell transfer.

We have validated the glycosphingolipid - binding non-toxic B - subunit of Shiga toxin as a delivery tool for cancer immunotherapy, and are currently building therapeutic vaccine prototypes for breast and head - and - neck cancers.

Turnstone's therapeutic platform is a first - in - class, tumor - targeted oncolytic vaccine that combines potent tumor - killing effects of oncolytic viruses with the benefits of a cancer vaccine that harnesses the patient's own immune system to fight disease in a sustainable manner.

Most recently, CRI has launched a new «venture philanthropy» program called the Cancer Vaccine Acceleration Fund (CVAF) as a means to catalyze development of next - generation therapeutic cancer vaccines and other immunotherapies by helping to address the critical shortage of capital available for early stage clinical tCancer Vaccine Acceleration Fund (CVAF) as a means to catalyze development of next - generation therapeutic cancer vaccines and other immunotherapies by helping to address the critical shortage of capital available for early stage clinical tcancer vaccines and other immunotherapies by helping to address the critical shortage of capital available for early stage clinical trials.

NEW YORK, NY — April 30, 2010 — The Cancer Research Institute celebrates yesterday's announcement of the first therapeutic cancer vaccine to receive approval from the U.S. Food and Drug AdministrCancer Research Institute celebrates yesterday's announcement of the first therapeutic cancer vaccine to receive approval from the U.S. Food and Drug Administrcancer vaccine to receive approval from the U.S. Food and Drug Administration.

«Based on the clinical evidence we've gathered over the past decade in our cancer vaccine trials,» Old said, «and in light of data from a variety of trials by others within the field, we believe therapeutic cancer vaccines will increasingly emerge as one of the safest and most powerful ways to combat a variety of cancers.»

Physicians with the Personalized Medicine Program at The Tisch Cancer Institute have initiated a phase I proof - of - concept study, a fully personalized multipeptide therapeutic vaccine designed to target tumor - derived neoantigens for individual patients.

The Focus: Deep dive into hot topics of therapeutic nutrition, biased research, the vaccine debate, and integrative cancer treatments.

It is focused on the development of preventive and therapeutic vaccine products and cancer drugs for patients with unmet medical needs.